ONWARD Medical | Company Profile - Revenue, Headcount, Tech Stack, Contacts

ONWARD Medical N.V. is a medical technology company based in Eindhoven, Netherlands, founded in 2014 as a spin-off from EPFL. The company focuses on developing therapies aimed at restoring movement, function, and independence for individuals with spinal cord injuries (SCI). It has achieved significant milestones, including 10 FDA Breakthrough Device Designations and raising EUR 50.85 million in 2025 to support global expansion.

Its product offerings include advanced spinal cord stimulation platforms for functional recovery after SCI. The ARC-EX System is the first FDA-cleared and CE-marked non-invasive therapy that enhances hand strength and sensation in chronic cervical SCI, available in over 50 clinics across the US. The ARC-IM® System provides implantable spinal stimulation for managing blood pressure instability and other SCI-related symptoms, with a pivotal study in progress. Additionally, the ARC-BCI is an implanted brain-computer interface aimed at restoring movement through thought. The company collaborates with various research institutions and clinics, emphasizing a commitment to innovation and patient-centered care.